Notal Vision SCANLY Home OCT
Save to shortlistLast reviewed Oct 31, 2026 against the sources listed on this page · How we review
At a glance
SCANLY Home OCT by Notal Vision is a patient-operated home OCT device for people with neovascular AMD.
- FDA:
- De Novo DEN230043
- Epic:
- Not on record
- Named users:
- Not on record
- Published study:
- Not on record
Description
SCANLY Home OCT by Notal Vision is a patient-operated home OCT device for people with neovascular AMD. AI software (the Notal OCT Analyzer) measures retinal fluid from daily scans and alerts the treating ophthalmologist to changes. FDA De Novo DEN230043, May 2024.
Quick answers
Answered only from the sourced records on this page. Questions we can't answer from the record are left out. How we review
- Is Notal Vision SCANLY Home OCT FDA cleared?
- The public FDA database has one record that our team matched to Notal Vision SCANLY Home OCT. The most recent is De Novo DEN230043 (Notal Vision Home Optical Coherence Tomography (OCT) System), decided May 2024. Check that the cleared use matches how you plan to use it.FDA record DEN230043
Security & contracting
The maker has not reported these details yet. Ask the vendor directly during evaluation.
- Workflow stage
- Not reported
- Integrations
- Not reported
- Data inputs
- Not reported
- Deployment
- Not reported
- Signs a BAA
- Not reported
- SOC 2 report
- Not reported
- HITRUST
- Not reported
- Evidence type
- Not assessed
Readiness details are self-reported by the maker and are not checked by Clinical Intelligence Foundry. Evidence type describes the kind of study or document the listing links to; it is not a rating or endorsement. Confirm compliance documents with the vendor before purchase.
Who's using this
Organizations named in public announcements or by the developer. Inclusion is not an endorsement.
No public deployments found yet (checked Oct 2026). Using this tool? The maker can claim the listing to add customers.
Get weekly updates for Ophthalmology
Up to 5 new items a week: new tools, FDA decisions and studies. Newest first, never ranked. Confirm by email, unsubscribe any time.
Sources
This listing links to primary sources. Follow the links below to check details directly with the developer, regulator or publication.
WebsiteFDA database records
- DEN230043 · De Novo · May 2024Notal Vision Home Optical Coherence Tomography (OCT) System
Matched by our team from the public FDA database; checked Nov 10, 2026.
History (2)Show
Dated events on this listing's public record, newest first.
- Oct 31, 2026
Added to CIFoundry
- May 15, 2024
FDA De Novo DEN230043 decision datesource
Developer
Notal Vision
Evaluating this tool?
Get a printable packet for your committee: what the public record shows, the gaps to raise with the vendor, and the questions for this kind of tool.
Prepare evaluation packetChecklist for your role: Admin · Physician · IT · Compliance
Compare similar tools →